The TARGT First Solid test by Bengaluru-based 4baseCare offers a comprehensive analysis of 72 commonly mutated genes, ...

New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...

A Bengaluru-based lab launched a free Lung NGS biomarker testing initiative for lung cancer patients in India, backed by the ...

This paper explores the potential of mitochondrial-associated programmed-cell-death (mtPCD) patterns as biomarkers for ...

The programme aims to enhance access to targeted cancer therapies by identifying actionable genetic mutations in lung cancer patients ...

For example, there had been a lack of accurate and effective biomarker for PD-L1 immunotherapy in advanced lung cancer, but our study on Theranostics in 2021 showed that machine learning might ...

The aim is to identify biomarkers for classifying lung cancer risk. “We’re doing that in the context of reaching rural and underserved areas,” Silvestri says. “Black people develop lung ...

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

In conclusion, ctDNA methylation in both tissue and plasma can effectively differentiate malignancy from benign disease and holds great potential as a biomarker for early lung cancer diagnosis.

In this webinar, you’ll hear how one of the largest multiomics observational studies to date has revealed lung cancer biomarkers from the blood plasma proteome. Our expert speakers will discuss how ...